Renal cell carcinoma (RCC) is the most common type of kidney cancer, accounting for 90% of all estimated cases. Advanced RCC often carries poor prognosis due to its high metastases rate, the lack of early-warning signs, as well as its complex clinical manifestations and its resistance to chemotherapy. Ethnopharmacologically, Fructus Rosae laevigata (JinYingZi) has been employed by Chinese medicine to treat various urinary tract and gastrointestinal dis¬orders. This study aimed at performing a series of mechanistic analyses in order to unlock the anticancer potential of JinYingZi-derived bioactive components against RCC. Several network pharmacology tools were employed so as to analyse the drug-disease interactions. Our data revealed that more than 2,214 genes were dysregulated in RCC, whereas the JinYingZi-derived bioactive compounds modulated 347 genes. The intersecting between RCC and the bioactive compounds revealed 132 cross targets. Our results were further validated by conducting molecular docking, which revealed a stable association between oleanolic acid with each of the following targets: androgen receptor (AR), dipeptidyl peptidase (DPP), estradiol (ESR1), nitric oxide synthase 2 (NOS2), and cyclooxygenase-2 (PTGS2). Our approach is being used successfully in order to evaluate a panel of novel medicinal plant-derived bioactive com¬pounds, and may lead to the identification of safe and effective chemical scaffolds that could act as templates for drug discovery or yield potential drug candidates.
9 April 2021 in Journal of Pharmaceutical Research International
Objectives: The present research has been conducted to assess the Nephroprotective effects of the Moringa Oleifera Extract against contrast -induced nephrotoxicity in male rabbits. Study Design: Experimental design Place and Duration of Study: it was carried out in the Faculty of Pharmacy/University of Kufa, Iraq/Al-Najaf Town .The study began at October 2020 and end at March 2021. Methodology: Twenty one adult (male rabbits) weighing range(1.2-1.5kg). Rabbits are divided in a random manner into three equal groups each group including seven rabbits. Group1:control group administered DW, Group2:has been treated with Iodide contrast(2.5mg/kg) of (370mg/ml),group 3: dosed alcoholic extracts of Moringa 250 mg/kg and contrast (2.5mg/kg).By accounting data on the MDA levels ,Glutathione level and features of kidney histopathology. All efforts have been made to reduce the suffering of a animals prior to and throughout the experiment and sampling. Results: The alcoholic Moringa extract at 250mg/kg body weight doses orally considerably protected contrast induced toxicity of the kidneys in the rabbits through the increment of the level of GSH and reduces the level of MDA. In the Histological data, the extract activities also protect the damage of the kidney, which is induced by the contrast that has been represented by the de-generation of some tubules and atrophy of glomerular, glomerular tuft congestion and expanded Bowman’s Space. Conclusions: This study proposed that Moringa’s alcoholic extract results in the enhancement of the defense status of the oxidative stress against the renal toxicity.(Moringa Oleifera have Nephroprotective effect against contrast induce Nephrotoxicity).
24 June 2022 in International journal of health sciences
Smoking is a condition in which a material is burned and the resulting smoke inhaled in to be tasted and absorbed into the circulation. Smoking and its complications are prevalent throughout the world but are most common in the Asia continent. The greatest rise in prevalence is, however, happening in middle and low-income countries including in Africa and Asia. Objective: To assess the prevalence of smoking and its complication among people in Iraq. Materials and Methods This is a randomized prospective clinical study, carried out in Al-Hakeem Hospital, Al-Sadr Medical city, and the Emergency Department. This study started in January 2021 and lasts for 4 months, was approved by the medical ethical community at the University of Kufa. The data was collected from the patient based on specific questionnaires. A sample of 60 cases in Al-Najaf governorate was chosen randomly from varying places where interview according to specialize questionnaire that included: age, sex, cigarette smoking per day, duration of smoking, complications that occur due to smoking. Results The prevalence of smoking complications was within the range of that reported in Iraq. A significant difference was founded between some smoking complications.
Aim: Background: Ischemia/reperfusion renal injury (IRI), which is predominantly brought on by inflammation and oxidative stress, is the main cause of acute kidney damage. Aims: This work uses a male Wistar Albino rat model of experimentally induced renal ischemia-reperfusion injury (IRI) to examine the nephroprotective potential of Urolithin A. Material and methods: Materials and methods: Twenty-eight rats (N=7) were randomly assigned to four groups: DMSO pre-injection as a vehicle, bilateral renal IRI for 30 minutes followed by two hours of reperfusion as a control, sham (laparotomy without IRI), and treatment (Urolithin A pre-injection for three days). ELISA and histological analysis were used to assess biomarkers of kidney injury, oxidative stress, inflammation, and apoptosis. Results: Results: While GSH levels were enhanced, Urolithin A therapy primarily decreased TNF-α, IL-1β, MDA, Caspase-3, and KIM-1 levels. Furthermore, the group treated with Urolithin A showed a substantial downregulation of FOXO3 expression. Histopathological results verified that the therapy group had less kidney damage. Conclusions: Conclusion: These findings suggest that Urolithin A produces nephroprotective effects against IRI via modulating oxidative stress, inflammation, and apoptosis, particularly through the control of FOXO3. This study suggests that Urolithin A is a good treatment candidate for renal IRI control.
6 April 2021 in Journal of Pharmaceutical Research International
Objectives: The study was conducted to evaluate the activity of different antibiotics used for various diseases and compare between their different effects among hospitalized patients. Study Design: Randomized prospected clinical study. Place and Duration of Study: It was carried out in Al-Zahraa Teaching Hospital and Al-Sader medical city, Iraq/Al-Najaf Town. The present study began at November 2017 and end at December 2018. Methodology: Sample of 100 patients in Al-Zahraa teaching Hospital and al-Sader Medical City, was randomly collected 90 cases in Al Sader Medical City ( 35 cases of medical ward and 55 cases from Surgical ward). We collected 10 medical condition in Al-Zahra Teaching Hospital from Gynecological and obstetric ward in random manner. Results: The results of present study reveal a significant difference between ceftriaxone and ceftazidime and meropenem in treatment intraabdominal operations infection (appendectomy and cholycystectomy) , the results of present study show that 70% of patient used ceftriaxone for treatment of appendectomy and only 30%of patients used ceftazidime for this condition so there is a significant difference between these two antibiotics (P-value less than 0.05) and only 10% of patients used meropenem (P-value less than 0.02). Other result of present study show significant difference in use meropenem over ceftriaxone in treatment diabetic foot ulcer(60% rate use meropenem over ceftriaxone 40%), in acute kidney injury, there's very high difference in use meropenem 80% versus 10% of vancomycin use (P-value 0.1). Conclusions: From current study we concluded that the antibiotics used greatly in surgical ward of Hospital followed by medical ward , in addition to that antibiotics used in postoperation are more effective than those used in medical ward , so there are a significant differences obtained among antibiotics used in surgical ward.
Aim: Background: Ischemia/reperfusion injury (IRI) is a major cause of kidney damage, primarily driven by oxidative stress and inflammation. Aims: This study investigates the protective effects of Carbenoxolone (Cbx) in attenuating renal injury through the modulation of the FOXO3 gene. Material and methods: Materials and methods: Twenty-eight adult male Wistar Albino rats were randomly divided into four groups (N=7): Sham (laparotomy without ischemia), Control (bilateral renal ischemia for 30 min followed by 2 h reperfusion), Vehicle (DMSO injection prior to IRI), and Carbenoxolone-treated (Cbx injection three days before IRI). Results: Results: Tissue levels of TNF-α, IL-1β, MDA, Caspase-3, and KIM-1 were significantly elevated in the control and vehicle groups, while GSH levels were reduced. Cbx treatment significantly decreased TNF-α, IL-1β, MDA, Caspase-3, and KIM-1 while increasing GSH levels, indicating enhanced antioxidant defense. FOXO3 expression was notably lower in the Cbx group compared to the control and vehicle groups. Histopathological analysis further confirmed reduced renal damage in Cbx-treated rats. These findings suggest that Cbx exerts renoprotective effects by mitigating oxidative stress, inflammation, and apoptosis. Conclusions: Conclusion: Carbenoxolone significantly reduces RIRI-induced kidney damage, demonstrating its potential as a therapeutic agent for renal ischemic injuries.